Literature DB >> 29799393

Distribution patterns of 18F-fluorodeoxyglucose in large vessels of Takayasu's and giant cell arteritis using positron emission tomography.

Alessandra Soriano1, Giulia Pazzola2, Luigi Boiardi1, Massimiliano Casali3, Francesco Muratore2, Nicolò Pipitone1, Mariagrazia Catanoso1, Raffaella Aldigeri4, Luca Cimino5, Annibale Versari3, Carlo Salvarani6.   

Abstract

OBJECTIVES: To compare patterns of vascular involvement using 18F-fluorodeoxyglucose-positron emission tomography computed tomography (FDG PET/CT) in patients with giant cell arteritis (GCA) and Takayasu's arteritis (TAK).
METHODS: A total of 130 consecutive 18F-FDG PET/CT scans performed during the disease course for evaluating disease activity in 15 GCA and 13 TAK patients were retrospectively examined by two nuclear physicians blinded to clinical data. Standardised uptake values (SUVmax) in 14 vascular districts including all the aortic segments and the main tributaries were measured. The average SUVmax value for each vascular district was also calculated. Principal component analysis (PCA) and agglomerative hierarchical cluster analysis (CA) were used to explore distribution patterns of vascular FDG uptake.
RESULTS: The aortic segments showed the highest SUV max values among the different districts in both GCA and TAK. SUV max values measured in the different districts were significantly higher in GCA compared to TAK, except for the axillary arteries. Regarding thoracic and abdominal aorta, ascending aorta and aortic arch had the highest correlation in both vasculitis (p<0.0001). CA confirmed that carotid, axillary, subclavian, iliac and femoral arteries clustered with their contralateral counterpart in both vasculitis. The 3 components of thoracic aorta clustered with abdominal aorta in TAK, while aortic arch clustered only with ascending aorta, and descending and abdominal aorta grouped together with iliac and femoral arteries in GCA. PCA analysis identified 3 different components for TAK and GCA explaining 72% and 71% of the total variance respectively in these two vasculitis. Confirming CA, a component including the entire aortic district was identified in TAK, but not in GCA. Similar results in PCA using averaged data were observed.
CONCLUSIONS: Strong similarities, but also a subtle skewing in terms of distribution patterns of arterial involvement assessed by SUVmax values were observed between GCA and TAK.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29799393

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  14 in total

1.  18F-FDG PET/CT plays a unique role in the management of Takayasu arteritis patients with atypical manifestations.

Authors:  Jiali Fan; Dongmei Wei; Huimin Zhang; Xiaoxin Sun; Jun Cai; Luyun Fan; Jiachen Yu; Wenjun Ma; Lei Song; Xianliang Zhou
Journal:  Clin Rheumatol       Date:  2020-06-19       Impact factor: 2.980

2.  The Role of Vascular Imaging to Advance Clinical Care and Research in Large-Vessel Vasculitis.

Authors:  Kaitlin A Quinn; Peter C Grayson
Journal:  Curr Treatm Opt Rheumatol       Date:  2019-02-09

3.  Patterns of Arterial Disease in Takayasu Arteritis and Giant Cell Arteritis.

Authors:  K Bates Gribbons; Cristina Ponte; Simon Carette; Anthea Craven; David Cuthbertson; Gary S Hoffman; Nader A Khalidi; Curry L Koening; Carol A Langford; Kathleen Maksimowicz-McKinnon; Carol A McAlear; Paul A Monach; Larry W Moreland; Christian Pagnoux; Kaitlin A Quinn; Joanna C Robson; Philip Seo; Antoine G Sreih; Ravi Suppiah; Kenneth J Warrington; Steven R Ytterberg; Raashid Luqmani; Richard Watts; Peter A Merkel; Peter C Grayson
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-11       Impact factor: 5.178

4.  Associations among temporal and large artery abnormalities on vascular ultrasound in giant cell arteritis.

Authors:  M A DiIorio; P S Sobiesczcyk; C Xu; W Huang; J A Ford; S S Zhao; D H Solomon; W P Docken; S K Tedeschi
Journal:  Scand J Rheumatol       Date:  2021-03-03       Impact factor: 3.057

5.  Clinical Factors Associated with Time-Specific Distribution of 18F-Fluorodeoxyglucose in Large-Vessel Vasculitis.

Authors:  Joel S Rosenblum; Kaitlin A Quinn; Casey A Rimland; Nehal N Mehta; Mark A Ahlman; Peter C Grayson
Journal:  Sci Rep       Date:  2019-10-23       Impact factor: 4.379

Review 6.  Cellular Signaling Pathways in Medium and Large Vessel Vasculitis.

Authors:  Ryu Watanabe; Gerald J Berry; David H Liang; Jörg J Goronzy; Cornelia M Weyand
Journal:  Front Immunol       Date:  2020-09-25       Impact factor: 7.561

7.  Use of Ultrasonography to Discriminate Psoriatic Arthritis from Fibromyalgia: A Post-Hoc Analysis of the ULISSE Study.

Authors:  Antonio Marchesoni; Pierluigi Macchioni; Stefania Gasparini; Carlo Perricone; Fabio Massimo Perrotta; Rosa Daniela Grembiale; Ettore Silvagni; Roberta Ramonda; Luisa Costa; Alen Zabotti; Giacomo Curradi; Giuliana Gualberti; Francesca Marando; Carlo Salvarani
Journal:  J Clin Med       Date:  2021-12-29       Impact factor: 4.241

Review 8.  An easy and practical guide for imaging infection/inflammation by [18F]FDG PET/CT.

Authors:  Alberto Signore; Massimiliano Casali; Chiara Lauri
Journal:  Clin Transl Imaging       Date:  2021-06-01

9.  Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation- (4Is) related cardiovascular diseases: a joint collaboration of the EACVI and the EANM: summary.

Authors:  Riemer H J A Slart; Andor W J M Glaudemans; Olivier Gheysens; Mark Lubberink; Tanja Kero; Marc R Dweck; Gilbert Habib; Oliver Gaemperli; Antti Saraste; Alessia Gimelli; Panagiotis Georgoulias; Hein J Verberne; Jan Bucerius; Christoph Rischpler; Fabien Hyafil; Paola A Erba
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2020-12-01       Impact factor: 6.875

10.  Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation (4Is)-related cardiovascular diseases: a joint collaboration of the EACVI and the EANM.

Authors:  Riemer H J A Slart; Andor W J M Glaudemans; Olivier Gheysens; Mark Lubberink; Tanja Kero; Marc R Dweck; Gilbert Habib; Oliver Gaemperli; Antti Saraste; Alessia Gimelli; Panagiotis Georgoulias; Hein J Verberne; Jan Bucerius; Christoph Rischpler; Fabien Hyafil; Paola A Erba
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-10-27       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.